Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Medtronic
Mallinckrodt
Harvard Business School
Baxter

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Strontium chloride sr-89 - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for strontium chloride sr-89 and what is the scope of freedom to operate?

Strontium chloride sr-89 is the generic ingredient in two branded drugs marketed by Q Biomed and Bio Nucleonics, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for strontium chloride sr-89.

Summary for strontium chloride sr-89
Recent Clinical Trials for strontium chloride sr-89

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ibn Sina HospitalN/A
Al Baraka Fertility HospitalN/A
Banon IVF Center Assiut, EgyptN/A

See all strontium chloride sr-89 clinical trials

Synonyms for strontium chloride sr-89
AC1L1VEK
AC1NSFZJ
AC1Q232M
ACMC-20ajmr
AHBGXTDRMVNFER-UHFFFAOYSA-L
AKOS030228140
CHEBI:36383
CHEMBL2219640
CTK0H6760
DB09498
Dichlorostrontium
DTXSID6040616
FT-0689177
J-001249
KS-00000YRS
KSC176O6B
MolPort-006-119-579
RT-000453
SC-79408
Strontium (89Sr) chloride
Strontium Chloride, Anhydrous
Strontium dichloride
Strontium(II) chloride
strontiumdichlorid

US Patents and Regulatory Information for strontium chloride sr-89

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bio Nucleonics STRONTIUM CHLORIDE SR-89 strontium chloride sr-89 INJECTABLE;INJECTION 075941-001 Jan 6, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
Q Biomed METASTRON strontium chloride sr-89 INJECTABLE;INJECTION 020134-001 Jun 18, 1993 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Colorcon
Dow
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.